Chelation therapy in beta-thalassemia: an optimistic update.
about
Future alternative therapies for β-thalassemia.The management of iron chelation therapy: preliminary data from a national registry of thalassaemic patientsMechanisms for the shuttling of plasma non-transferrin-bound iron (NTBI) onto deferoxamine by deferiprone.Advances in iron chelation: an update.The impact of polyether chain length on the iron clearing efficiency and physiochemical properties of desferrithiocin analogues.Design of iron chelators with therapeutic application.Monensin improves the effectiveness of meso-dimercaptosuccinate when used to treat lead intoxication in ratsPharmacotherapy of iron overload in thalassaemic patients.Current and future therapy in haemochromatosis and Wilson's disease.Impact of iron overload and potential benefit from iron chelation in low-risk myelodysplastic syndromeIneffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin.Desferrithiocin analogue iron chelators: iron clearing efficiency, tissue distribution, and renal toxicityTreating thalassemia major-related iron overload: the role of deferiprone.Future chelation monotherapy and combination therapy strategies in thalassemia and other conditions. comparison of deferiprone, deferoxamine, ICL670, GT56-252, L1NAll and starch deferoxamine polymers.The impact of iron overload and its treatment on quality of life: results from a literature review.Substituent effects on desferrithiocin and desferrithiocin analogue iron-clearing and toxicity profiles.Hepcidin and Hfe in iron overload in beta-thalassemia.Impact of the 3,6,9-trioxadecyloxy group on desazadesferrithiocin analogue iron clearance and organ distribution.Frequency of Hereditary Hemochromatosis (HFE) Gene Mutations in Egyptian Beta Thalassemia Patients and its Relation to Iron Overload.Design, synthesis, and testing of non-nephrotoxic desazadesferrithiocin polyether analogues.The ICET-A Recommendations for the Diagnosis and Management of Disturbances of Glucose Homeostasis in Thalassemia Major Patients.Desferrithiocin analogues and nephrotoxicity.Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β-thalassemia.Gene therapy in thalassemia and hemoglobinopathies.Different approaches to the study of chelating agents for iron and aluminium overload pathologies.Pattern of iron chelation therapy in Egyptian beta thalassemic patients: Mansoura University Children's Hospital experience.Safety profiles of iron chelators in young patients with haemoglobinopathies.Iron chelation in thalassemia: time to reconsider our comfort zones.beta-Thalassemia: HiJAKing Ineffective Erythropoiesis and Iron OverloadStudy of serum haptoglobin level and its relation to erythropoietic activity in Beta thalassemia childrenHealth-Related Quality of Life, Treatment Satisfaction, Adherence and Persistence in β-Thalassemia and Myelodysplastic Syndrome Patients with Iron Overload Receiving Deferasirox: Results from the EPIC Clinical TrialPersistence and compliance of deferoxamine versus deferasirox in Medicaid patients with sickle-cell disease.Study of intermittent intravenous deferrioxamine high-dose therapy in heavily iron-loaded children with beta-thalassemia major poorly compliant to subcutaneous injections.Effective combination therapy of deferiprone and deferoxamine for the rapid clearance of excess cardiac IRON and the prevention of heart disease in thalassemia. The Protocol of the International Committee on Oral Chelators.
P2860
Q33659678-8FD4FC41-7A44-443E-8905-3E6DFA8F7278Q33955451-AE65A1A6-9DF3-43ED-9889-F2175682BE0BQ34083003-D43616FE-0EE9-413B-99B5-6EC520B9A05AQ34174307-962FA632-8FDC-4F06-98E3-45A7F8C3B2ADQ34181082-92A8C806-016C-40D8-8C48-F9BD3ED2C8E1Q34258805-F136F392-50AD-48B2-BBBC-1EFE0E7C6DC5Q34547063-A00EF2B3-A2F2-42EE-B636-FF4070BFFC0EQ35548173-168288DD-9FE2-4FD4-A5F0-C21E13A9BA9FQ35593984-F531B84C-D7D0-4033-9D8D-97AD4C284E41Q35743810-58F88F53-EDC4-4275-B8C0-D0C20C7AB9C0Q35828757-67A3D114-6C19-4E7B-B881-C60629FABA9AQ35896606-87E037FF-B8AC-4772-8294-63DE4E4FCFEDQ36344669-23E75C37-46E9-4DD6-88FC-D0D91EA2F05BQ36518462-FEC2A920-066E-4ED4-81AB-5512885DFE36Q36606351-5A24C7B3-BAA3-4EBD-A01E-85815FB326D9Q36642048-05E59B8A-E21A-4729-B1F1-B0D843DED59DQ36838907-F50E8983-35DE-459B-AC41-979DF16B5722Q36857692-842ABB54-5C91-4C11-9FB5-9397A9090A8EQ37006570-4A513B45-A7A0-4DE4-8E9F-92BEEA946353Q37381807-530AD55E-AB70-4B50-AD1E-D600A4D4461AQ37417551-CA0EDCE2-4418-46CF-BB30-617D4C1A666EQ37423512-2472D84F-CCC6-498E-85F5-7EBEB9616C48Q37809337-B7C6AE0D-2D6B-49C9-9A89-DE96091FF573Q37854468-7BCA0C58-A52C-4055-BAAD-5A7A1ABC1CD0Q38055398-3A25A614-93B5-47B5-B9B9-FBCE542A0094Q38855966-32E9663F-BA08-4949-81BB-459552811C84Q39022073-8C8E1BD6-D962-4056-ADEB-DC1AD1A14BD8Q39782885-802A55BA-E994-4700-AA19-0A32265F53BCQ40659209-95DABE03-FBB9-43A1-A519-AC2931EABC6BQ41446592-A9473D68-FDD1-4D15-84C8-7BBC24A8C8FFQ42098491-EF47541E-6D07-4967-AD2D-05846A626036Q44101608-EC3AEE3D-B390-4C61-945D-F37E5E634001Q44942521-5C4E0639-918C-4372-9292-B45940DE2DD0Q51173696-12C77EFD-560D-43A2-BB2B-B7029F68C977
P2860
Chelation therapy in beta-thalassemia: an optimistic update.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Chelation therapy in beta-thalassemia: an optimistic update.
@ast
Chelation therapy in beta-thalassemia: an optimistic update.
@en
Chelation therapy in beta-thalassemia: an optimistic update.
@nl
type
label
Chelation therapy in beta-thalassemia: an optimistic update.
@ast
Chelation therapy in beta-thalassemia: an optimistic update.
@en
Chelation therapy in beta-thalassemia: an optimistic update.
@nl
prefLabel
Chelation therapy in beta-thalassemia: an optimistic update.
@ast
Chelation therapy in beta-thalassemia: an optimistic update.
@en
Chelation therapy in beta-thalassemia: an optimistic update.
@nl
P1476
Chelation therapy in beta-thalassemia: an optimistic update.
@en
P2093
P304
P356
10.1016/S0037-1963(01)90030-7
P577
2001-10-01T00:00:00Z